Kestenberg-Messina Kaitlin M.'s Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Aug 30, 2024
- Accession no.
- 0001140361-24-039822
- Filed
- Aug 30, 2024
- Trade date
- Aug 30, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $408.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kestenberg-Messina Kaitlin M.CIK 0002017423 | Officer (COO and SVP, Compliance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 | Common Stock | MOption exerciseAcquired | +8,125 | $2.35 | +$19,093.75 | 457,213 | Direct | |
| Aug 30, 2024 | Common Stock | MOption exerciseAcquired | +4,375 | $2.59 | +$11,331.25 | 461,588 | Direct | |
| Aug 30, 2024 | Common Stock | MOption exerciseAcquired | +6,650 | $5.94 | +$39,501 | 468,238 | Direct | |
| Aug 30, 2024 | Common Stock | MOption exerciseAcquired | +5,000 | $4.72 | +$23,600 | 473,238 | Direct | |
| Aug 30, 2024 | Common Stock | SSaleDisposed | −24,150 | $16.90F1 | −$408,135 | 449,088 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 | Common Stock | MOption exerciseDisposed | −8,125 | $2.35 | −$19,093.75 | 3,750 | Direct | |
| Aug 30, 2024 | Common Stock | MOption exerciseDisposed | −4,375 | $2.59 | −$11,331.25 | 0 | Direct | |
| Aug 30, 2024 | Common Stock | MOption exerciseDisposed | −6,650 | $5.94 | −$39,501 | 0 | Direct | |
| Aug 30, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $4.72 | −$23,600 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $16.72 to $17.02. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.